/RHHVF

RHHVF Stock - Roche Holding AG

Q: What is the analyst price target for RHHVF?

Analyst price target information is not currently available for RHHVF.

Q: What is RHHVF's market cap?

Market capitalization information is not currently available for RHHVF.

Healthcare|Drug Manufacturers - General|OTC

$416.11+3.94%

+$15.78 (+3.94%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $457.72

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for RHHVF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.17

52W High$420.28

52W Low$269.80

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$62.40B	$60.44B	$63.28B	$62.80B	$58.32B
Gross Profit	$46.11B	$44.08B	$42.88B	$43.15B	$42.15B
Gross Margin	73.9%	72.9%	67.8%	68.7%	72.3%
Operating Income	$13.42B	$15.39B	$17.48B	$18.16B	$18.54B
Net Income	$8.28B	$11.50B	$12.42B	$13.93B	$14.29B
Net Margin	13.3%	19.0%	19.6%	22.2%	24.5%
EPS	$10.39	$14.40	$15.53	$16.39	$16.72

Company Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.

Visit Website

Earnings History & Surprises

RHHVF

Beat Rate

Last 12 quarters

Avg Surprise

-25.4%

EPS vs Estimate

Beats / Misses

0/12

Last 12 quarters

Latest EPS

$11.61

Q2 2025

EPS Surprise History

Q4 21

-26.9%

$7.81vs$10.68

Q2 22

-4.7%

$10.99vs$11.53

Q4 22

-44.6%

$5.26vs$9.49

Q2 23

-14.8%

$9.90vs$11.62

Q4 23

-37.0%

$6.34vs$10.07

Q2 24

-16.4%

$8.71vs$10.42

Q4 24

-70.1%

$2.77vs$9.25

Q2 25

-11.9%

$11.61vs$13.18

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Jan 29, 2026	—	—	—	—
Q2 2025	Jun 30, 2025	$13.18	$11.61	-11.9%	✗ MISS
Q4 2024	Dec 31, 2024	$9.25	$2.77	-70.1%	✗ MISS
Q2 2024	Jun 29, 2024	$10.42	$8.71	-16.4%	✗ MISS
Q4 2023	Dec 31, 2023	$10.07	$6.34	-37.0%	✗ MISS
Q2 2023	Jun 30, 2023	$11.62	$9.90	-14.8%	✗ MISS
Q4 2022	Dec 31, 2022	$9.49	$5.26	-44.6%	✗ MISS
Q2 2022	Jun 30, 2022	$11.53	$10.99	-4.7%	✗ MISS
Q4 2021	Dec 31, 2021	$10.68	$7.81	-26.9%	✗ MISS
Q2 2021	Jun 30, 2021	$10.96	$9.80	-10.6%	✗ MISS
Q4 2020	Dec 31, 2020	$9.96	$8.14	-18.3%	✗ MISS
Q2 2020	Jun 30, 2020	$11.18	$9.87	-11.7%	✗ MISS
Q4 2019	Dec 31, 2019	$9.30	$5.75	-38.2%	✗ MISS
Q2 2019	Jun 30, 2019	—	$10.20	—	—
Q4 2018	Dec 31, 2018	—	$3.80	—	—
Q2 2018	Jun 30, 2018	—	$8.55	—	—
Q4 2017	Dec 31, 2017	—	$3.72	—	—
Q2 2017	Jun 30, 2017	—	$6.64	—	—
Q4 2016	Dec 31, 2016	—	$4.78	—	—
Q2 2016	Jun 30, 2016	—	$6.40	—	—

Frequently Asked Questions about RHHVF

What is RHHVF's current stock price?

Roche Holding AG (RHHVF) is currently trading at $416.11 per share. The stock has moved +3.94% today.

What is the analyst price target for RHHVF?

No analyst price targets are currently available for this stock.

What sector is Roche Holding AG in?

Roche Holding AG operates in the Healthcare sector, specifically within the Drug Manufacturers - General industry. The company is traded on the OTC exchange.

What is RHHVF's market cap?

Roche Holding AG has a market capitalization of $331.43 billion, making it a mega-cap company.

Does RHHVF pay dividends?

No, Roche Holding AG does not currently pay a dividend to shareholders.